{"schema_version":"secwatch.filing_event.v1","accession":"0001516551-22-000052","form_type":"8-K","ticker":"SKYE","cik":"0001516551","company_name":"Skye Bioscience, Inc.","filed_at":"2022-11-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.940602+00:00","generated_at":"2026-06-21T13:23:15.005362+00:00","sec_items":["1.01","3.03","9.01"],"event_type":"debt","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Skye Bioscience prepays $945K debt, extends maturity, reprices warrants to $0.017","bullets":["Prepaid $944,862 of principal and interest; remaining convertible debt of $1.848M.","Maturity of credit agreement extended to December 30, 2022.","Exercise price of 16.6M Emerald warrants reduced from $0.50/$0.151 to $0.017 per share.","Company agreed to negotiate registration rights for shares underlying warrants.","Warrant repricing significantly increases potential future dilution for existing shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001516551-22-000052","json":"https://secwatch.observer/filing/0001516551-22-000052.json","markdown":"https://secwatch.observer/filing/0001516551-22-000052.md","text":"https://secwatch.observer/filing/0001516551-22-000052.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1516551/000151655122000052/0001516551-22-000052-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1516551/000151655122000052/skye-20221117.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T13:23:15.005362+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6b8186585dc3431fd368d2d1b3c87942bc5f6e18","claim":"Skye Bioscience, Inc. amended Amendment and Acknowledgement Agreement with Emerald Health Sciences, Inc. (effective 2022-11-17).","evidence_excerpt":"On November 17, 2022, Skye Bioscience, Inc. (the \"Company\") entered into an Amendment and Acknowledgement Agreement (the \"Amendment Agreement\") with Emerald Health Sciences, Inc. (\"Emerald\").","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655122000052/0001516551-22-000052-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"credit facility"},{"label":"Counterparty","value":"Emerald Health Sciences, Inc."},{"label":"Effective","value":"2022-11-17"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}